share_log

藥明康德:海外監管公告

WUXI APPTEC: Overseas Regulatory Notice

HKEX ·  Jul 29 08:25
Summary by Moomoo AI
無錫藥明康德新藥開發股份有限公司於2024年7月29日宣布,根據2019年限制性股票與股票期權激勵計劃,將注銷7名激勵對象尚未行權的股票期權共31,509份。該決定是在第三屆董事會第十二次會議及第三屆監事會第九次會議上通過的。注銷的原因是這些激勵對象在期權行權期屆滿前離職或未在行權期內行權。公司表示,此次注銷不會對公司的經營業績產生重大影響。監事會已審查並同意注銷行動,認為符合相關法律法規及激勵計劃的規定,並無損公司及全體股東利益。
無錫藥明康德新藥開發股份有限公司於2024年7月29日宣布,根據2019年限制性股票與股票期權激勵計劃,將注銷7名激勵對象尚未行權的股票期權共31,509份。該決定是在第三屆董事會第十二次會議及第三屆監事會第九次會議上通過的。注銷的原因是這些激勵對象在期權行權期屆滿前離職或未在行權期內行權。公司表示,此次注銷不會對公司的經營業績產生重大影響。監事會已審查並同意注銷行動,認為符合相關法律法規及激勵計劃的規定,並無損公司及全體股東利益。
Wuxi Apptec announced on July 29, 2024 that, according to the 2019 Restricted Stock and Stock Option Incentive Plan, it will cancel a total of 31,509 unexercised stock options for 7 incentive targets. The decision was made at the 12th meeting of the third Board of Directors and the ninth meeting of the third Supervisory Board. The reason for the cancellation is that these incentive targets resigned before the expiration of the option exercise period or did not exercise the options during the exercise period. The company stated that this cancellation will not have a significant impact on the company's operations. The Supervisory Board has reviewed and approved the cancellation action, believing that it complies with relevant laws and regulations and the provisions of the incentive plan, and does not harm the interests of the company and all shareholders.
Wuxi Apptec announced on July 29, 2024 that, according to the 2019 Restricted Stock and Stock Option Incentive Plan, it will cancel a total of 31,509 unexercised stock options for 7 incentive targets. The decision was made at the 12th meeting of the third Board of Directors and the ninth meeting of the third Supervisory Board. The reason for the cancellation is that these incentive targets resigned before the expiration of the option exercise period or did not exercise the options during the exercise period. The company stated that this cancellation will not have a significant impact on the company's operations. The Supervisory Board has reviewed and approved the cancellation action, believing that it complies with relevant laws and regulations and the provisions of the incentive plan, and does not harm the interests of the company and all shareholders.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more